Organogenesis Holdings Inc. (ORGO)
USD 4.33
(1.64%)
USD 4.33
(1.64%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 4.94 Million USD | -68.16% |
| 2022 | 15.53 Million USD | -83.51% |
| 2021 | 94.2 Million USD | 446.61% |
| 2020 | 17.23 Million USD | 142.6% |
| 2019 | -40.45 Million USD | 37.6% |
| 2018 | -64.83 Million USD | -2996.16% |
| 2017 | -2.09 Million USD | -903.32% |
| 2016 | -208.69 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -17.04 Million USD | -711.57% |
| 2024 Q1 | -2.1 Million USD | -269.72% |
| 2023 Q1 | -2.96 Million USD | -139.66% |
| 2023 FY | 4.94 Million USD | -68.16% |
| 2023 Q4 | -568 Thousand USD | -104.69% |
| 2023 Q3 | 12.1 Million USD | 127.75% |
| 2023 Q2 | 5.31 Million USD | 279.05% |
| 2022 Q2 | 8.74 Million USD | 9950.57% |
| 2022 Q1 | 87 Thousand USD | -99.83% |
| 2022 FY | 15.53 Million USD | -83.51% |
| 2022 Q4 | 7.48 Million USD | 3381.86% |
| 2022 Q3 | 215 Thousand USD | -97.54% |
| 2021 Q2 | 20.68 Million USD | 108.06% |
| 2021 FY | 94.2 Million USD | 446.61% |
| 2021 Q1 | 9.94 Million USD | -46.24% |
| 2021 Q4 | 51.69 Million USD | 311.03% |
| 2021 Q3 | 12.57 Million USD | -39.2% |
| 2020 Q2 | -5.16 Million USD | 68.33% |
| 2020 FY | 17.23 Million USD | 142.6% |
| 2020 Q4 | 18.49 Million USD | -11.66% |
| 2020 Q3 | 20.93 Million USD | 505.23% |
| 2020 Q1 | -16.31 Million USD | -270.92% |
| 2019 Q1 | -15.66 Million USD | -69.27% |
| 2019 FY | -40.45 Million USD | 37.6% |
| 2019 Q4 | -4.39 Million USD | 59.05% |
| 2019 Q3 | -10.74 Million USD | -11.32% |
| 2019 Q2 | -9.64 Million USD | 38.41% |
| 2018 Q3 | 4.93 Million USD | 1282.79% |
| 2018 Q4 | -9.25 Million USD | -287.48% |
| 2018 FY | -64.83 Million USD | -2996.16% |
| 2018 Q1 | -135.65 Thousand USD | 72.77% |
| 2018 Q2 | 356.98 Thousand USD | 363.16% |
| 2017 Q2 | 380.33 Thousand USD | 170.0% |
| 2017 Q3 | -2.11 Million USD | -656.62% |
| 2017 FY | -2.09 Million USD | -903.32% |
| 2017 Q4 | -498.1 Thousand USD | 76.47% |
| 2017 Q1 | 140.86 Thousand USD | 179.07% |
| 2016 FY | -208.69 Thousand USD | 0.0% |
| 2016 Q2 | -500.00 USD | 96.78% |
| 2016 Q4 | -178.15 Thousand USD | -1129.34% |
| 2016 Q3 | -14.49 Thousand USD | -2798.4% |
| 2016 Q1 | -15.55 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 48.15 Million USD | 89.731% |
| Embecta Corp. | 70.4 Million USD | 92.976% |
| ANI Pharmaceuticals, Inc. | 18.77 Million USD | 73.667% |
| Dynavax Technologies Corporation | -6.38 Million USD | 177.399% |
| Esperion Therapeutics, Inc. | -209.24 Million USD | 102.363% |
| Pacira BioSciences, Inc. | 41.95 Million USD | 88.214% |
| PainReform Ltd. | -9.34 Million USD | 152.922% |
| Aquestive Therapeutics, Inc. | -7.87 Million USD | 162.834% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | 209.741% |
| SCYNEXIS, Inc. | 67.04 Million USD | 92.624% |
| China SXT Pharmaceuticals, Inc. | -3.09 Million USD | 259.592% |
| Cosmos Health Inc. | -18.54 Million USD | 126.668% |
| Journey Medical Corporation | -3.85 Million USD | 228.342% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | 209.741% |
| Safety Shot Inc | -15.08 Million USD | 132.785% |
| Alpha Teknova, Inc. | -36.78 Million USD | 113.445% |
| Intra-Cellular Therapies, Inc. | -139.67 Million USD | 103.54% |
| Bright Green Corporation | -13.12 Million USD | 137.669% |
| Procaps Group, S.A. | 42.54 Million USD | 88.376% |
| Theratechnologies Inc. | -23.95 Million USD | 120.641% |
| Harrow Health, Inc. | -24.41 Million USD | 120.257% |
| Sonoma Pharmaceuticals, Inc. | -4.83 Million USD | 202.275% |
| Biofrontera Inc. | -20.13 Million USD | 124.564% |
| DURECT Corporation | -27.62 Million USD | 117.901% |
| Supernus Pharmaceuticals, Inc. | 1.31 Million USD | -275.76% |
| Cronos Group Inc. | -73.96 Million USD | 106.686% |
| OptiNose, Inc. | -35.48 Million USD | 113.936% |
| Ironwood Pharmaceuticals, Inc. | -1 Billion USD | 100.493% |
| Kala Pharmaceuticals, Inc. | -42.19 Million USD | 111.718% |
| RedHill Biopharma Ltd. | 23.91 Million USD | 79.323% |
| Guardion Health Sciences, Inc. | 158.03 Thousand USD | -3029.093% |
| Cumberland Pharmaceuticals Inc. | -6.27 Million USD | 178.751% |
| Radius Health, Inc. | -25.79 Million USD | 119.173% |
| Universe Pharmaceuticals INC | -6.16 Million USD | 180.236% |
| ProPhase Labs, Inc. | -16.78 Million USD | 129.466% |
| Phibro Animal Health Corporation | 2.41 Million USD | -104.677% |
| Procaps Group S.A. | 42.54 Million USD | 88.376% |
| Alvotech | -551.73 Million USD | 100.896% |
| TherapeuticsMD, Inc. | -10.27 Million USD | 148.112% |
| Viatris Inc. | 54.7 Million USD | 90.96% |
| Rockwell Medical, Inc. | -8.43 Million USD | 158.597% |
| Aytu BioPharma, Inc. | -15.84 Million USD | 131.211% |
| SIGA Technologies, Inc. | 68.06 Million USD | 92.735% |
| Tilray Brands, Inc. | -244.98 Million USD | 102.019% |
| Lifecore Biomedical, Inc. | 12.01 Million USD | 58.836% |
| Shineco, Inc. | -22.44 Million USD | 122.028% |
| PetIQ, Inc. | 2.13 Million USD | -132.051% |
| Regencell Bioscience Holdings Limited | -4.3 Million USD | 214.951% |
| Incannex Healthcare Limited | -18.45 Million USD | 126.789% |
| Neurocrine Biosciences, Inc. | 249.7 Million USD | 98.02% |
| Alimera Sciences, Inc. | -20.13 Million USD | 124.563% |
| Silver Spike Investment Corp. | 7.34 Million USD | 32.63% |
| Assertio Holdings, Inc. | -331.94 Million USD | 101.49% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6.59 Million USD | 175.007% |
| Petros Pharmaceuticals, Inc. | -8.16 Million USD | 160.577% |
| Clever Leaves Holdings Inc. | -17.89 Million USD | 127.627% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 124.654% |
| Avadel Pharmaceuticals plc | -160.27 Million USD | 103.085% |
| Hempacco Co., Inc. | -13.12 Million USD | 137.673% |
| Talphera, Inc. | -18.39 Million USD | 126.879% |
| Alvotech | -551.73 Million USD | 100.896% |
| Eagle Pharmaceuticals, Inc. | 35.64 Million USD | 86.126% |
| Lantheus Holdings, Inc. | 326.66 Million USD | 98.486% |
| Currenc Group, Inc. | -15.3 Million USD | 132.306% |
| Kamada Ltd. | 8.28 Million USD | 40.307% |
| Indivior PLC | 2 Million USD | -147.25% |
| Evoke Pharma, Inc. | -7.79 Million USD | 163.46% |
| Flora Growth Corp. | -57.03 Million USD | 108.67% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 124.654% |
| Evolus, Inc. | -61.68 Million USD | 108.017% |
| HUTCHMED (China) Limited | 100.78 Million USD | 95.093% |
| Amphastar Pharmaceuticals, Inc. | 137.54 Million USD | 96.405% |
| Akanda Corp. | -32.27 Million USD | 115.321% |